Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Development -- Clinical Aspects of Pharmaceutical Portfolio Management -- Drug Development and the Cost of Capital -- Investment Considerations for Pharmaceutical Product Portfolios -- Challenges of...

Using the example of corporate OSS engagement, Oliver Alexy shows how free revealing can be carried out both effectively and efficiently by companies. He evaluates potential advantages and disadvantages and looks at related organizational processes to understand how this practice diffuses within...